AAAAAA

   
Results: 1-16 |
Results: 16
IMPROVED OUTCOME IN RECIPIENTS OF HLA IDENTICAL T-CELL DEPLETED ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANTS CONTAINING HIGH-DOSES OF STEM-CELLS
Authors: MATTAR B CARABASI MH TILDEN AB SALZMAN D MARTIN B KUNKEL L VAUGHAN WP
Citation: B. Mattar et al., IMPROVED OUTCOME IN RECIPIENTS OF HLA IDENTICAL T-CELL DEPLETED ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANTS CONTAINING HIGH-DOSES OF STEM-CELLS, Blood, 90(10), 1997, pp. 4421-4421
RAPID IMMUNE RECONSTITUTION IN RECIPIENTS OF T-CELL DEPLETED PERIPHERAL-BLOOD STEM-CELL TRANSPLANTS FROM ALA IDENTICAL SIBLINGS
Authors: CARABASI MH TILDEN AB SHRESTRA K SALZMAN D MARTIN B VAUGHAN WP KUNKEL L BUCY RP
Citation: Mh. Carabasi et al., RAPID IMMUNE RECONSTITUTION IN RECIPIENTS OF T-CELL DEPLETED PERIPHERAL-BLOOD STEM-CELL TRANSPLANTS FROM ALA IDENTICAL SIBLINGS, Blood, 90(10), 1997, pp. 2415-2415
AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION FOR POOR-PROGNOSISLOW-GRADE LYMPHOMA
Authors: FREYTES CO VUKELJA S SALZMAN D TSAI T CALLANDER N GOKMEN E RODRIGUEZ T CASTRO J BOLDT D ROODMAN GD HILSENBECK S ADKINS D BACHIER C CRAIG F CLARE N WEISNER A LEMAISTRE CF
Citation: Co. Freytes et al., AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION FOR POOR-PROGNOSISLOW-GRADE LYMPHOMA, Experimental hematology, 24(9), 1996, pp. 629-629
MALIGNANCY-ASSOCIATED PULMONARY VENOOCCLUSIVE DISEASE - REPORT OF A CASE FOLLOWING AUTOLOGOUS BONE-MARROW TRANSPLANTATION AND REVIEW
Authors: SALZMAN D ADKINS DR CRAIG F FREYTES C LEMAISTRE CF
Citation: D. Salzman et al., MALIGNANCY-ASSOCIATED PULMONARY VENOOCCLUSIVE DISEASE - REPORT OF A CASE FOLLOWING AUTOLOGOUS BONE-MARROW TRANSPLANTATION AND REVIEW, Bone marrow transplantation, 18(4), 1996, pp. 755-760
PHARMACOLOGICAL MECHANISM OF PATHOLOGICAL HYPERALGESIA IN NEUROPATHICPAIN - THE ROLE OF THE ALPHA(2B)-ADRENERGIC RECEPTOR
Authors: LEVY RM LEIPHART J DILLS C SALZMAN D
Citation: Rm. Levy et al., PHARMACOLOGICAL MECHANISM OF PATHOLOGICAL HYPERALGESIA IN NEUROPATHICPAIN - THE ROLE OF THE ALPHA(2B)-ADRENERGIC RECEPTOR, Journal of neurosurgery, 84(2), 1996, pp. 840-840
IMPACT OF CD8 DEPLETED DONOR LEUKOCYTE INFUSIONS ON IMMUNE FUNCTION IN RECIPIENTS OF HLA-IDENTICAL T-CELL DEPLETED ALLOGENEIC BONE-MARROW TRANSPLANTS
Authors: CARABASHI MH TILDEN AB SHRESTRA K SALZMAN D MARTIN B VAUGHAN WP LEBKOWSKI JS BUCY RP
Citation: Mh. Carabashi et al., IMPACT OF CD8 DEPLETED DONOR LEUKOCYTE INFUSIONS ON IMMUNE FUNCTION IN RECIPIENTS OF HLA-IDENTICAL T-CELL DEPLETED ALLOGENEIC BONE-MARROW TRANSPLANTS, Blood, 88(10), 1996, pp. 1831-1831
DOSE-ESCALATION STUDY OF HIGH-DOSE CARBOPLATIN AND ETOPOSIDE WITH AUTOLOGOUS BONE-MARROW SUPPORT IN PATIENTS WITH RECURRENT AND REFRACTORY GERM-CELL TUMORS
Authors: BROUN ER NICHOLS CR MANDANAS R SALZMAN D TURNS M HROMAS R CORNETTA K EINHORN LH
Citation: Er. Broun et al., DOSE-ESCALATION STUDY OF HIGH-DOSE CARBOPLATIN AND ETOPOSIDE WITH AUTOLOGOUS BONE-MARROW SUPPORT IN PATIENTS WITH RECURRENT AND REFRACTORY GERM-CELL TUMORS, Bone marrow transplantation, 16(3), 1995, pp. 353-358
HIGH-DOSE CHEMOTHERAPY (HDC) AND AUTOLOGOUS BLOOD OR MARROW TRANSPLANTATION FOR NON-HODGKINS-LYMPHOMA (NHL) AND HODGKINS-DISEASE (HD) AT RISK FOR PULMONARY COMPLICATIONS
Authors: SALZMAN D CARABASI MA BRIGGS AD GEILS GF VAUGHAN WP
Citation: D. Salzman et al., HIGH-DOSE CHEMOTHERAPY (HDC) AND AUTOLOGOUS BLOOD OR MARROW TRANSPLANTATION FOR NON-HODGKINS-LYMPHOMA (NHL) AND HODGKINS-DISEASE (HD) AT RISK FOR PULMONARY COMPLICATIONS, Blood, 86(10), 1995, pp. 3840-3840
AUGMENTED CYCLOPHOSPHAMIDE (C), CARMUSTINE (B) AND ETOPOSIDE (V) + - DACARBAZINE (D) WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION (BMT) FOR RELAPSED OR REFRACTORY HODGKINS-DISEASE - LOWER PERITRANSPLANT MORTALITY AND ANALYSIS OF PROGNOSTIC FACTORS/
Authors: TSAI T SALZMAN D CLARK G CASTRO J CALLANDER N BOLDT D ROODMAN GD SHERIDANLEOS N WIESNER A ADKINS D HARRIS K RODRIGUEZ T GOKMEN E LEMAISTRE CF FREYTES CO
Citation: T. Tsai et al., AUGMENTED CYCLOPHOSPHAMIDE (C), CARMUSTINE (B) AND ETOPOSIDE (V) + - DACARBAZINE (D) WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION (BMT) FOR RELAPSED OR REFRACTORY HODGKINS-DISEASE - LOWER PERITRANSPLANT MORTALITY AND ANALYSIS OF PROGNOSTIC FACTORS/, Blood, 86(10), 1995, pp. 3865-3865
PHASE-I TRIAL OF DACARBAZINE WITH CYCLOPHOSPHAMIDE, CARMUSTINE, ETOPOSIDE, AND AUTOLOGOUS STEM-CELL TRANSPLANTATION IN PATIENTS WITH LYMPHOMA AND MULTIPLE-MYELOMA
Authors: ADKINS DR SALZMAN D BOLDT D KUHN J IRVIN R ROODMAN GD LYONS R SMITH L FREYTES CO LEMAISTRE CF
Citation: Dr. Adkins et al., PHASE-I TRIAL OF DACARBAZINE WITH CYCLOPHOSPHAMIDE, CARMUSTINE, ETOPOSIDE, AND AUTOLOGOUS STEM-CELL TRANSPLANTATION IN PATIENTS WITH LYMPHOMA AND MULTIPLE-MYELOMA, Journal of clinical oncology, 12(9), 1994, pp. 1890-1901
CRYOPRESERVED MATCHED RELATED DONOR MARROW ENGRAFTS PROMPTLY FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: CASTRO J BACHIER C BOLDT DH FREYTES C HARRIS K ROODMAN D SALZMAN D TAMI J MENEGHETTI C SHERIDANLEOS N LEMAISTRE CF
Citation: J. Castro et al., CRYOPRESERVED MATCHED RELATED DONOR MARROW ENGRAFTS PROMPTLY FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION, Blood, 84(10), 1994, pp. 10000093-10000093
CLINICAL REMISSION OF MYASTHENIA-GRAVIS (MG) IN A PATIENT (PT) AFTER HIGH-DOSE THERAPY AND AUTOLOGOUS TRANSPLANTATION WITH CD34-CELLS (SC)(STEM)
Authors: SALZMAN D TAMI J JACKSON C CASTRO J BOLDT D FREYTES C BERENSON R LEMAISTRE CF
Citation: D. Salzman et al., CLINICAL REMISSION OF MYASTHENIA-GRAVIS (MG) IN A PATIENT (PT) AFTER HIGH-DOSE THERAPY AND AUTOLOGOUS TRANSPLANTATION WITH CD34-CELLS (SC)(STEM), Blood, 84(10), 1994, pp. 10000206-10000206
BONE-MARROW TRANSPLANTATION (BMT) FOR ADULT POOR-RISK HIGH-GRADE NON-HODGKINS-LYMPHOMA (HGNHL)
Authors: BACHIER C FREYTES CO SALZMAN D CASTRO J BOLDT D ROODMAN GD HARRIS K CRAIG F WIESNER A LEMAISTRE CF
Citation: C. Bachier et al., BONE-MARROW TRANSPLANTATION (BMT) FOR ADULT POOR-RISK HIGH-GRADE NON-HODGKINS-LYMPHOMA (HGNHL), Blood, 84(10), 1994, pp. 10000703-10000703
HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM-CELL RESCUE IN RESISTANT OR RECURRENT LOW-GRADE LYMPHOMA
Authors: FREYTES CO BACHIER C SALZMAN D VUKELIA S CASTRO J BOLDT D ROODMAN GD CRAIG F HARRIS K TSAI T SHERIDANLEOS N HILSENBECK S TAMI J BURRELL L LEMAISTRE CF
Citation: Co. Freytes et al., HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM-CELL RESCUE IN RESISTANT OR RECURRENT LOW-GRADE LYMPHOMA, Blood, 84(10), 1994, pp. 10000709-10000709
DURABLE COMPLETE REMISSION IN A PATIENT WITH REFRACTORY MEDIASTINAL NONSEMINOMATOUS GERM-CELL TUMOR AFTER TANDEM HIGH-DOSE CHEMOTHERAPY ANDAUTOLOGOUS BONE-MARROW TRANSPLANTATION
Authors: ADKINS D ENCARNACION C SALZMAN D BOLDT D FREYTES C VONHOFF DD LEMAISTRE CF
Citation: D. Adkins et al., DURABLE COMPLETE REMISSION IN A PATIENT WITH REFRACTORY MEDIASTINAL NONSEMINOMATOUS GERM-CELL TUMOR AFTER TANDEM HIGH-DOSE CHEMOTHERAPY ANDAUTOLOGOUS BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 12(5), 1993, pp. 541-546
A PHASE-I CLINICAL AND PHARMACOLOGICAL PROFILE OF DACARBAZINE WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN PATIENTS WITH SOLID TUMORS
Authors: ADKINS DR IRVIN R KUHN J BOLDT DH ROODMAN GD SALZMAN D FREYTES C VONHOFF DD LEMAISTRE CF
Citation: Dr. Adkins et al., A PHASE-I CLINICAL AND PHARMACOLOGICAL PROFILE OF DACARBAZINE WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN PATIENTS WITH SOLID TUMORS, Investigational new drugs, 11(2-3), 1993, pp. 169-179
Risultati: 1-16 |